Fintwit Blog

Smarter investing, one post at a time

Actionable investing insights, AI-powered stock research, and tips to help you make smarter investment decisions.

Featured · AI for Investing

AI for Investing

How to Use ChatGPT for Stock Research (2026) | 11 Best Prompts

11 copy-paste ChatGPT prompts for equity research, plus a better alternative at half the price.

AI for Investing

How to Use Claude for Stock Research (2026) | Copy-Paste Prompts

11 Claude prompts for equity research and earnings analysis, plus an automated alternative.

AI for Investing

How to Use Google Gemini for Stock Research (2026) | Best Prompts

11 Gemini prompts for equity research, plus how Fintwit automates the whole flow.

All
AI for Investing
Stock Analysis

Latest

Stock Analysis

NVIDIA Corporation (NVDA): The AI Infrastructure Powerhouse

NVIDIA (NVDA) remains the foundational architect of global AI. We break down the financials, competitive moat, and the latest analyst sentiment.

Stock Analysis

AutoZone Inc (AZO) Q3 Earnings Preview: What to Watch

AutoZone reports Q3 2026 earnings on May 26. We break down the consensus estimates, key segment growth, and the impact of LIFO charges on margins.

Stock Analysis

Zscaler Inc (ZS) Q3 Earnings Preview: What to Watch

Zscaler enters Q3 with raised ARR guidance. We analyze the key metrics, analyst sentiment, and the path forward for the cybersecurity leader.

Stock Analysis

Zscaler Inc (ZS) Q3 Earnings Preview: What to Watch

Zscaler enters Q3 with 40 upward EPS revisions. We analyze the key metrics, competitive pressures, and management guidance ahead of the May 26 report.

Stock Analysis

Daniel Loeb's Third Point Q1 2026 Portfolio Shift: META, GOOGL, and LRCX

Third Point's Q1 2026 13F shows Daniel Loeb exiting Microsoft and slashing NVIDIA to rotate into Meta, Alphabet, and Lam Research.

Stock Analysis

Should You Buy ALAB Right Now? Analyzing Astera Labs' AI Momentum

Astera Labs (ALAB) is up over 200% in a year. Is the AI infrastructure play still a buy at a 100x P/E ratio?

Stock Analysis

Should You Buy Guardant Health (GH) After Its 17% Post-Earnings Surge?

Guardant Health shares surged 17% on strong Q1 results. We break down the bull and bear cases for this high-growth diagnostics player.

Stock Analysis

Abivax SA (ABVX) Q Earnings Preview: What to Watch

Abivax (ABVX) approaches its May 25 earnings report with eyes on Phase 3 clinical milestones and a potential U.S. NDA filing in late 2026.

Stock Analysis

Abivax SA (ABVX) Q1 2026 Earnings Preview: What to Watch

Abivax enters Q1 2026 with strong analyst backing. We break down the clinical milestones and financial metrics to watch ahead of the May 25 report.

Get smarter investing insights, free.

Join thousands of investors using Fintwit for AI stock analysis, real-time signals from X, and curated daily picks.

Free to start. Premium just $9.99/mo.